TSUTOMU TAMADA1, YUICHI KOJIMA1, AYUMU KIDO1, YU UEDA2, MITSURU TAKEUCHI3, KENTARO ONO1, MIDORI YAMAMOTO1, AKIRA YAMAMOTO1, and YOSHIHIKO FUKUKURA1
1Radiology, Kawasaki Medical School, Kurashiki-city, Japan, 2Philips Japan, Tokyo, Japan, 3Radiology, Radiolonet Tokai, Nagoya, Japan
Synopsis
Keywords: Prostate, Prostate
We
compared diagnostic performance of clinically significant PC (csPC) between calculated
DWI (calDWI) which enable to synthesize DW images with any TR and TE and native
acquired single-shot EPI DWI (nDWI). The calDWI
was generated with TR of 1000 and TE of 0 ms. Three
radiologists independently assessed eight regions of each prostate by PI-RADS v
2.1 DWI score. For diagnostic performance of csPC, AUC was
comparable between calDWI and nDWI in two readers. The diagnostic specificity was
significantly higher in calDWI than in nDWI in two readers. Compared with nDWI, calDWI had similar or higher diagnostic performance in csPC.
INTRODUCTION
DWI
is key component of multiparametric MRI (mpMRI) in prostate. However, single-shot
echo-planar DWI (ssEPI DWI) with higher b-value more than 1400 s/mm2,
which is commonly used in daily clinical practice, still shows insufficient
image contrast between benign and malignant prostatic tissues. Recently, it has
been reported that shorter TR can improve diffusion contrast compared to
conventional (long) TR1, utilizing the prostate uniqueness that T1
of prostate cancer (PC) is lower than that of benign prostatic tissue2-4.
However, such a short TR leads to a decrease in SNR. We have previously reported
calculated DWI (calDWI) which enable to adjust any TR as well as any TE in
prostate5. Compared to conventional native acquired ssEPI DWI (nDWI),
calDWI with shorter TR and TE tended to have better diffusion contrast5.
The purpose of this study is to compare diagnostic performance of clinically
significant PC (csPC) between calDWI and nDWI.METHODS
The
subjects were 34 patients with csPC who underwent mpMRI on Ingenia Elition 3.0T
(Philips Healthcare, Best, The Netherlands) and radical prostatectomy. For DWI
with b-value of 2000 s/mm2 (b2000),
nDWI was scanned with TR of 6000 and TE of 70 ms. CalDWI was generated with TR
of 1000 ms to utilize T1 shine-through and TE of 0 ms to remove T2
shine-through completely. T2 shine-through in DW images is not efficient in
prostate due to shorter T26 in PC.
Three radiologists with 1 year (Reader 1), 11
years (Reader 2), and 25 years (Reader
3) of experience in prostate MRI interpretation) independently assessed eight
prostate regions (six peripheral zone: right apex, right middle, right base,
left apex, left middle, and left base; and two transition zones: right
transition zone and left transition zone) of each patient by DWI score in
PI-RADS v 2.17. PI-RADS v2.1 DWI score ≥3 was considered positive
for csPC detection. First, only nDWI was evaluated first, and three weeks
later, both nDWI and calDWI were evaluated in combination. In both sessions, T2-weighted
imaging was used to provide anatomical information in addition to DW images. As
another session, for the index lesion with the highest GS and largest
size among the csPCs of each patient, qualitative lesion
conspicuity score (LCS) based on 4-point Likert scales (1=invisible for
surrounding normal site; 2=slightly high, 3=moderately high; 4=very high) and quantitative tumor contrast ratio (CR =
(lesion mean signal intensity (LSI) - benign PZ mean signal intensity (BSI)) /
(LSI+BSI)) were assessed.RESULTS
For
diagnostic performance of csPC using DWI score, AUC was significantly higher in
calDWI than in nDWI in reader 3 (0.855 vs. 0.805 in reader 3 (P=0.004)), and
was comparable between calDWI and nDWI in reader 1 and 2 (0.731 vs. 0.716 in
reader 2 (P=0.630) and 0.771 vs. 0.776 in reader 2 (P=0.728)). The diagnostic
specificity was significantly higher in calDWI than in nDWI in reader 1 (0.758
vs. 0.608, P = 0.003) and reader 3 (0.900 vs. 0.683, P < 0.001, respectively),
but not in reader 2 (0.717 vs. 0.775, P = 0.118). There was no significant
difference in diagnostic sensitivity between nDWI and calDWI in three readers (0.700
to 0.767 vs. 0.658 to 0.775, P=0.052 to P=1.000). LCS was comparable between calDWI
and nDWI in three readers (P=0.145 to P=0.967).
CR in calDWI was significantly higher than that in nDWI (0.65±0.14 vs. 0.37±0.11,
P < 0.001).DISCUSSION
Using
prostatectomy as the reference standard, we compared diagnostic performance for
csPC detection between nDWI and calDWI. The
quantitative lesion conspicuities for csPC are higher in calDWI than in nDWI. This may be due to the increased
signal intensity of PC lesion caused by the enhanced T1 shine-through effect
from short TR and the decreased signal intensity of benign prostatic regions
caused by the suppression of the T2 shine-through effect from the short TE. Regarding
the diagnostic performance of csPC detection using the DWI score of PI-RADS
v2.1 in PC patients who underwent prostatectomy, diagnostic sensitivity and AUC
were comparable between nDWI and calDWI in three readers and two readers,
respectively. However, the diagnostic specificity was higher in calDWI than tha
in nDWI in two readers. This increase in diagnostic specificity for csPC, i.e.,
high true nagative and low false positive rates, should be attributed to the signal
suppression of high-signal benign prostatic lesions such as chronic prostatitis
and beign prostatic hyperplasia and high-signal benign prostatic structures
including central zone and anterior fibromuscular stroma in DWI. The high
contrast resolution between benign prostatic tissues and csPC and the high
diagnostic specificity can be clinically beneficial for two situations. First,
it will contribute to improving the diagnostic performance of radiologists and
urologists who do not have sufficient experience in prostate MRI diagnosis. Second,
the number of unnecessary biopsies and needle biopsies can be reduced.DISCUSSION
Compared with nDWI, calDWI had similar or
higher diagnostic performance of csPC. In particular, high detection
specificity for csPC in calDWI might be beneficial to avoid unnecessary
biopsies.Acknowledgements
No acknowledgement found.References
1.
Ueda
Y, Tamada T, Yoshida K, et al. Short TR DWI in prostate.
Proceedings of the 28th Annual Meeting of ISMRM, 2020 #2423.
2.
Shiradkar R, Panda A, Leo
P, et al. T1 and T2 MR fingerprinting measurements of prostate cancer and
prostatitis correlate with deep learning-derived estimates of epithelium,
lumen, and stromal composition on corresponding whole mount histopathology. Eur
Radiol 2021; 31: 1336-46.
3.
Baur ADJ, Hansen CM,
Rogasch J, et al. Evaluation of T1 relaxation time in prostate cancer and
benign prostate tissue using a Modified Look-Locker inversion recovery sequence.
Sci Rep 2020;10(1):3121.
4.
Panda
A, Obmann VC , Lo WC, et al. MR fingerprinting and ADC
mapping for characterization of lesions in the transition zone of the prostate
gland. Radiology 2019; 292: 685-94.
5.
Ueda
Y, Tamada T, Sanai H, et al. Feasibility of synthetic
short TR and short TE DWI in prostate cance. Proceedings of the 29th Annual
Meeting of ISMRM, 2021 #3711
6.
Liu W, Turkbey B, Sénégas
J, et al. Accelerated T2 mapping for characterization of prostate cancer. Magn
Reson Med 2011;65(5):1400-1406.
7.
Turkbey
B, Rosenkrantz AB, Haider MA, et al. Prostate Imaging
Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging
Reporting and Data System Version 2. Eur Urol 2019;76(3):340-351.